E. Baker

First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient

D. Forton, M. Klammer, Y. Reyal, 2020, EJHaem.

Validation of recombinant Sendai virus in a non-natural host model

T. Shu, M. Hasegawa, G. Mclachlan, 2011, Gene Therapy.

Kinetics of efficient recombinant adeno-associated virus transduction in retinal pigment epithelial cells.

P. Rakoczy, F. Rolling, Y. K. Lai, 2001, Experimental cell research.